glp 1 agonists adverse effects drug side Managing Side Effects of GLP-1 Receptor – Transformation Weight Control GI Adverse Effects of Glucagon-Like
Description
DPP-4 inhibitors degrade certain entero-hormones (e.g., glucose-dependent insulinotropic peptide (GIP) and glucagon-like peptide-1 (GLP-1)), or incretins, which are primarily produced within minutes [9]
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early alzheimers disease with lecanemab, an anti-abeta protofibril antibody
Are GLP-1s safe for long-term use
doi: 10.1080/13543784.2024.2377319 23
Koehler JA, Baggio LL, Yusta B, Longuet C, Rowland KJ, Cao X, et al
Jastreboff, A.M., et al., Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial
